Cardiome Pharma Corp. (CRME)

0.02 0.95
NASDAQ : Health Technology
Prev Close 2.10
Open 2.16
Day Low/High 2.08 / 2.17
52 Wk Low/High 1.29 / 4.84
Volume 35.32K
Avg Volume 163.40K
Exchange NASDAQ
Shares Outstanding 31.88M
Market Cap 81.99M
EPS -0.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Biotech Stocks Face Make-or-Break FDA Rulings

Several drugmakers face key approval votes in 2008.

Feuerstein's Biotech-Stock Mailbag

Micro-cap Advanced Life Sciences faces a tough road.

Monday's Winners and Losers: Hoku Scientific

The clean energy products shop climbs 44% on a supply deal.

Monday's Health Winners & Losers

Medivation falls in response to a new sell rating.

Biotech's Hot Season: Get Ready

With summer in the books, it's time to start preparing for this sector's time of the year.

Cardiome Slips on FDA Delay

The regulatory agency requests a panel and more clinical data for arrhythmia drug Vernakalant.

It's Time to Shop for Cheap Biotech Stocks

The lazy days of summer bring out the bargains.

Parsing Dodd's Financial Ties

The Connecticut senator has a personal connection to the current executive compensation bill.

Cardiome Sets Stock Sale

The company will offer 8 million shares.

Wednesday's Health Winners & Losers

Wednesday's Health Winners & Losers

Cardiome Pharma is one of the day's decliners.

Wednesday's Health Winners & Losers

Cardiome sinks after an FDA disappointment.

FDA Setback Clobbers Cardiome

The company's shares plunge 20%.

Health Stocks in Motion

Health Stocks in Motion

Health Stocks in Motion

CTI Molecular surges after agreeing to a buyout.